These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 18821067)

  • 21. [Management of stage I testicular nonseminomatous germ cell tumors with an embryonic carcinomatous component. 18 cases].
    Drianno N; Robert M; Legouffe E; Guiter J; Navratil H
    Prog Urol; 1997 Sep; 7(4):622-7. PubMed ID: 9410322
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of clinical stage I testicular pure seminoma. Report on 42 patients and review of the literature.
    Porcaro AB; Antoniolli SZ; Schiavone D; Maffei N; Bassetto MA; Curti P
    Arch Ital Urol Androl; 2002 Jun; 74(2):77-80. PubMed ID: 12161941
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Late relapses (>2 years) in patients with stage I testicular germ cell tumors: predictive factors and survival.
    Fedyanin M; Tryakin A; Kanagavel D; Bulanov A; Burova A; Figurin K; Fainshtein I; Sergeev U; Zakharova T; Garin A; Tjulandin S
    Urol Oncol; 2013 May; 31(4):499-504. PubMed ID: 21803619
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term efficacy of two cycles of BEP regimen in high-risk stage I nonseminomatous testicular germ cell tumors with embryonal carcinoma and/or vascular invasion.
    Chevreau C; Mazerolles C; Soulié M; Gaspard MH; Mourey L; Bujan L; Plante P; Rischmann P; Bachaud JM; Malavaud B
    Eur Urol; 2004 Aug; 46(2):209-14; discussion 214-5. PubMed ID: 15245815
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survival of patients with viable malignant non-seminomatous germ cell tumour persistent after cisplatin-based induction chemotherapy.
    Hollender A; Stenwig EA; Ous S; Fosså SD
    Eur Urol; 1997; 31(2):141-7. PubMed ID: 9076455
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Use of prognostic factors of disease progression in the treatment of patients with stage I nonseminomatous testicular tumors].
    Ondrus D
    Bratisl Lek Listy; 1999 Jan; 100(1):61-5. PubMed ID: 10493000
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adjuvant bleomycin, vincristine and cisplatin (BOP) for high-risk stage I non-seminomatous germ cell tumours: a prospective trial (MRC TE17).
    Dearnaley DP; Fossa SD; Kaye SB; Cullen MH; Harland SJ; Sokal MP; Graham JD; Roberts JT; Mead GM; Williams MV; Cook PA; Stenning SP;
    Br J Cancer; 2005 Jun; 92(12):2107-13. PubMed ID: 15928672
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evolution and controversies in the management of low-stage nonseminomatous germ-cell tumors of the testis.
    Pizzocaro G; Nicolai N; Salvioni R
    World J Urol; 1994; 12(3):113-9. PubMed ID: 7524920
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quality-of-Life Analysis of the German Prospective Multicentre Trial of Single-cycle Adjuvant BEP Versus Retroperitoneal Lymph Node Dissection in Clinical Stage I Nonseminomatous Germ Cell Tumours.
    Flechtner HH; Fischer F; Albers P; Hartmann M; Siener R;
    Eur Urol; 2016 Mar; 69(3):518-25. PubMed ID: 26620368
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low-volume nodal metastases detected at retroperitoneal lymphadenectomy for testicular cancer: pattern and prognostic factors for relapse.
    Rabbani F; Sheinfeld J; Farivar-Mohseni H; Leon A; Rentzepis MJ; Reuter VE; Herr HW; McCaffrey JA; Motzer RJ; Bajorin DF; Bosl GJ
    J Clin Oncol; 2001 Apr; 19(7):2020-5. PubMed ID: 11283135
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current management of stage I testicular non-seminomatous germ cell tumours.
    Pectasides D; Pectasides E; Constantinidou A; Aravantinos G
    Crit Rev Oncol Hematol; 2009 May; 70(2):114-23. PubMed ID: 18805019
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Etoposide and cisplatin adjuvant therapy for patients with pathologic stage II germ cell tumors.
    Motzer RJ; Sheinfeld J; Mazumdar M; Bajorin DF; Bosl GJ; Herr H; Lyn P; Vlamis V
    J Clin Oncol; 1995 Nov; 13(11):2700-4. PubMed ID: 7595727
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of testicular seminoma advanced disease. Report on 14 cases and review of the literature.
    Porcaro AB; Antoniolli SZ; Maffei N; Beltrami P; Bassetto MA; Curti P
    Arch Ital Urol Androl; 2002 Jun; 74(2):81-5. PubMed ID: 12161942
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk-adapted treatment of clinical stage 1 non-seminoma testis cancer.
    Klepp O; Dahl O; Flodgren P; Stierner U; Olsson AM; Oldbring J; Nilsson S; Daehlin L; Tørnblom M; Småland R; Starkhammar H; Abramsson L; Wist E; Raabe N; Edekling T; Cavallin-Ståhl E
    Eur J Cancer; 1997 Jun; 33(7):1038-44. PubMed ID: 9376184
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Treatment of stage I non-seminomatous germ cell tumors of the testis].
    Droz JP
    Presse Med; 1995 Oct; 24(32):1501-3. PubMed ID: 8545352
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adjuvant chemotherapy for stage I non-seminomatous testicular cancer.
    Abratt RP; Pontin AR; Barnes RD; Reddi BV
    S Afr Med J; 1994 Sep; 84(9):605-7. PubMed ID: 7530863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nonseminomatous germ cell testicular tumors clinical stage I: differentiated therapeutic approach in comparison with therapeutic approach using surveillance strategy only.
    Ondrus D; Ondrusova M; Hornak M; Matoska J
    Neoplasma; 2007; 54(5):437-42. PubMed ID: 17688374
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk-adapted treatment in clinical stage I nonseminomatous germ cell testicular cancer: the SWENOTECA management program.
    Tandstad T; Dahl O; Cohn-Cedermark G; Cavallin-Stahl E; Stierner U; Solberg A; Langberg C; Bremnes RM; Laurell A; Wijkstrøm H; Klepp O
    J Clin Oncol; 2009 May; 27(13):2122-8. PubMed ID: 19307506
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Treatment outcome on 52 patients with 53 testicular germ cell tumors].
    Yokoyama M; Nemoto K; Kanemura M; Kitahara K; Oda H; Murata H; Matsunaga Y
    Hinyokika Kiyo; 1998 Nov; 44(11):789-94. PubMed ID: 9893223
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is bleomycin necessary in adjuvant chemotherapy of clinical stage I non-seminomatous testicular cancer?
    Mezvrishvili Z; Managadze L
    Georgian Med News; 2006 May; (134):25-8. PubMed ID: 16783058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.